09:33:26 EDT Mon 06 Jul 2026
Enter Symbol
or Name
USA
CA



Redwood AI Corp. - Common Shares
Symbol AIRX
Shares Issued 37,314,553
Close 2026-07-03 C$ 2.95
Market Cap C$ 110,077,931
Recent Sedar+ Documents

ORIGINAL: Redwood AI Provides Update on its Definitive Agreement with Quantum.IQ

2026-07-06 07:30 ET - News Release

(via TheNewswire)

Redwood AI Corp.
 

Vancouver, Canada – TheNewswire - July 6, 2026 – Redwood AI Corp. (CSE: AIRX ) (OTCQB: RDWCF ) (Frankfurt: Y0N , WKN: A422EZ ) (“Redwood ” or the “Company ”) is pleased to announce, further to its news releases dated May 28, 2026 and June 26, 2026, that the Company intends to complete the acquisition (the “Acquisition ”) of Quantum.IQ Technologies Inc. (“Quantum.IQ ”) on or about July 10, 2026, subject to the satisfaction or waiver of customary closing conditions. The Acquisition will be completed pursuant to a share purchase agreement among Redwood, Quantum.IQ and the shareholders of Quantum.IQ dated June 26, 2026 (the “Purchase Agreement ”).

Completion of the Acquisition remains subject to customary closing conditions, including receipt of all required corporate, regulatory and stock exchange approvals, execution and delivery of the escrow agreement, the absence of any material adverse change affecting either Redwood or Quantum.IQ, and other conditions customary for a transaction of this nature. There can be no assurance that the Acquisition will be completed on the terms contemplated by the Purchase Agreement, or at all.

 

The Company intends to issue 50,000 common shares of the Company to an arm’s-length third party as an administrative fee for their assistance with the Acquisition and such shares will be subject to a four-month and one day hold period in accordance with applicable securities laws.

 

About Redwood AI Corp.

 

Redwood uses advanced artificial intelligence to accelerate chemistry R&D, with the aim of assisting in drug discovery and development, and furthering defence and safety solutions. The Company combines expertise in chemistry, AI, and manufacturing to streamline drug synthesis and scale-up. Redwood’s platform is designed to enable faster, more efficient development of new therapies and chemistry-driven applications.

ON BEHALF OF REDWOOD AI CORP.,

 

“Louis Dron ”

Chief Executive Officer

For more information, please contact:

 

Louis Dron

Chief Executive Officer

 

Tel: +1 888 530 8488

investors@redwoodai.com

 

The CSE and Information Service Provider have not reviewed and do not accept responsibility for the accuracy or adequacy of this release.

 

Forward-Looking Statements Caution

This news release contains statements and information that, to the extent they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information in this news release includes, without limitation, statements regarding: (i) the acquisition of Quantum.IQ, including the satisfaction of closing conditions, receipt of regulatory approvals and the anticipated timing and completion thereof.

Forward-looking information is generally identified by words such as “believe”, “expect”, “anticipate”, “estimate”, “intend”, “plan”, “may”, “should”, “will”, “potential” and similar expressions. Although the Company believes that the expectations and assumptions underlying the forward-looking information are reasonable, such information is subject to significant risks and uncertainties, many of which are beyond the Company’s control, including, without limitation: the risk that the Acquisition is not completed due to failure to obtain required regulatory approvals, or to satisfy or waive other closing conditions; risks relating to closing timing and market conditions; the early-stage and evolving nature of quantum cybersecurity and artificial intelligence technologies.

Actual results, performance or achievements could differ materially from those expressed in, or implied by, such forward-looking information. Accordingly, readers should not place undue reliance on forward-looking information. The forward-looking information contained in this news release is made as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law.

 

Copyright (c) 2026 TheNewswire - All rights reserved.

© 2026 Canjex Publishing Ltd. All rights reserved.